Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae

Trum, M. and Schollmeier, E. and Riechel, J. and Lebek, S. and Reuthner, K. and Keller, K. and Wester, M. and Provaznik, Z. and Schmid, C. and Maier, L. and Arzt, M. and Wagner, S. (2022) Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae. In: ESC Congress 2022, 26. - 29. August 2022, Barcelona, Spain.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Herz-, Thorax- und herznahe Gefäßchirurgie
Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 07 Sep 2023 05:41
Last Modified: 07 Sep 2023 05:41
URI: https://pred.uni-regensburg.de/id/eprint/56536

Actions (login required)

View Item View Item